D/B/A Centerspace Common Stock (CSR)

57.99
+5.28 (10.02%)
NYSE· Last Trade: Sep 9th, 3:37 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Centerspace (NYSE – CSR), Fulcrum Therapeutics, Inc. (Nasdaq – FULC), Weave Communications, Inc. (NYSE – WEAV), Bio-Techne Corporation (Nasdaq – TECH)
BALA CYNWYD, Pa., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
By Brodsky & Smith LLC · Via GlobeNewswire · September 9, 2026
CSR Stock Alert: Halper Sadeh LLC is Investigating Whether Centerspace is Obtaining a Fair Price for its Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Centerspace (NYSE: CSR) to Independence Realty Trust, Inc. for 3.800 shares of Independence Realty common stock for each share of Centerspace common stock.
By Halper Sadeh LLC · Via Business Wire · September 9, 2026
Independence Realty Trust and Centerspace to Merge in $8.1 Billion Combination
Independence Realty Trust, Inc. (NYSE: IRT) ("IRT") and Centerspace (NYSE: CSR) ("Centerspace") today announced that they have entered into a definitive merger agreement under which Centerspace and IRT will combine in an all-stock transaction, creating a leading middle-market multifamily REIT focused on high-growth, non-gateway markets. The combined company is expected to have a pro forma equity market capitalization of approximately $5.0 billion and a total enterprise value of approximately $8.1 billion.
By Independence Realty Trust, Inc. · Via Business Wire · September 9, 2026